ADM Korea Inc
KOSDAQ:187660
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indo Amines Ltd
NSE:INDOAMIN
|
IN |
|
Gibus SpA
MIL:GBUS
|
IT |
|
S
|
Skarbiec Holding SA
WSE:SKH
|
PL |
ADM Korea Inc
EPS (Diluted)
ADM Korea Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
EPS (Diluted)
-₩319
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
EPS (Diluted)
₩40.9k
|
CAGR 3-Years
33%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
EPS (Diluted)
-₩595
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-10%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
EPS (Diluted)
₩2.6k
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
EPS (Diluted)
-₩191
|
CAGR 3-Years
31%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
EPS (Diluted)
-₩2k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-14%
|
|
ADM Korea Inc
Glance View
ADM Korea, Inc. engages in providing clinical operations. The company is headquartered in Seoul, Seoul. The company went IPO on 2021-06-03. The firm is a contract research organization (CRO) that provides clinical trial related services to pharmaceutical companies and bio ventures. The firm also provides post-marketing research (rPMS) services.
See Also
What is ADM Korea Inc's EPS (Diluted)?
EPS (Diluted)
-319.5
KRW
Based on the financial report for Dec 31, 2025, ADM Korea Inc's EPS (Diluted) amounts to -319.5 KRW.
What is ADM Korea Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
33%
Over the last year, the EPS (Diluted) growth was 33%.